Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Twist Bioscience Corporation

< Previous 1 2 3 4 5 Next >
Twist Bioscience and Biotia Receive Expanded Emergency Use Authorization to Report Genetic Variants of SARS-CoV-2
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Report Fiscal 2022 Third Quarter Financial Results on Friday, August 5, 2022
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Launches Monkeypox Virus Synthetic DNA Controls
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Opens New Twist Boston Location to Expand Antibody Discovery Capacity
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at Fujifilm’s 12th Annual Global IT Executive Summit
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Launches Rapid Turnaround, Customizable Panels to Advance R&D in Minimal Residual Disease (MRD) Detection in Cancer Screening
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at Upcoming Investor Conferences
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Launches Human Methylome Panel to Enable Detection of Methylation Fractions in a Diverse Range of Applications
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at the 2022 UBS Global Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Announces Participation in SRC Panel at the 2022 MRS Spring Meeting and Exhibit
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Enters into Research, Exclusive Option and License Agreement with Astellas for Antibodies to Reduce Tumor Microenvironment-Mediated Immunosuppression
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Reports Second Quarter 2022 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Highlights Synthetic Libraries and High Throughput Antibody Discovery Platform at PEGS Boston 2022
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Launches High Throughput Antibody Production Platform
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Become Voting Member of Storage Networking Industry Association
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Announces Promotions and Changes to Executive Leadership Team
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Report Fiscal 2022 Second Quarter Financial Results on Thursday, May 5, 2022
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Signs Antibody Discovery Collaboration with MediSix Therapeutics to Develop T-cell Therapies
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience and Ginkgo Bioworks Sign New Collaboration
From Twist Bioscience Corporation
Via Business Wire
Tickers DNA TWST
Twist Bioscience Launches Synthetic RNA Positive Controls for SARS-CoV-2 Encapsulated in Imagene’s Stainless Steel Capsules
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Becomes Digital Preservation Coalition Supporter
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at Upcoming Virtual Conferences
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Announces Pricing of an Upsized $250 Million Public Offering of Common Stock
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Announces Proposed Public Offering of Common Stock
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
C2i Genomics Partners with Twist Bioscience to Launch Reference Materials for Whole-Genome Cancer Detection
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience and Eleven Therapeutics Create Replicon for Development of Antiviral Tools
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback